Aspirin Resistance

Overview

Journal BMJ

Specialty General Medicine

Date 2004 Feb 28

PMID 14988166

Citations 14

Authors

Graeme J Hankey

John W Eikelboom

Affiliations

Soon will be listed here.

Citing Articles

Comparison of Different Laboratory Tests to Identify "Aspirin Resistance" and Risk of Vascular Events among Ischaemic Stroke Patients: A Double-Blind Study.

Venketasubramanian N, Agustin S, Padilla J, Yumul M, Sum C, Lee S J Cardiovasc Dev Dis. 2022; 9(5).

PMID: 35621867 PMC: 9145610. DOI: 10.3390/jcdd9050156.

Biomarkers for Antiplatelet Therapies in Acute Ischemic Stroke: A Clinical Review.

Alhazzani A, Venkatachalapathy P, Padhilahouse S, Sellappan M, Munisamy M, Sekaran M Front Neurol. 2021; 12:667234.

PMID: 34177775 PMC: 8222621. DOI: 10.3389/fneur.2021.667234.

Performance comparison of aspirin assay between Anysis and VerifyNow: Assessment of therapeutic platelet inhibition in patients with cardiac diseases.

Piao J, Yoo C, Kim S, Whang Y, Choi C, Shin S Clin Hemorheol Microcirc. 2021; 79(2):327-334.

PMID: 33967038 PMC: 8673509. DOI: 10.3233/CH-211171.

Point-of-Care-Testing in Acute Stroke Management: An Unmet Need Ripe for Technological Harvest.

Harpaz D, Eltzov E, Seet R, Marks R, Tok A Biosensors (Basel). 2017; 7(3).

PMID: 28771209 PMC: 5618036. DOI: 10.3390/bios7030030.

Aspirin treatment failure: is this a real phenomenon? A review of the aetiology and how to treat it.

Shahid F, Chahal C, Akhtar M JRSM Short Rep. 2013; 4(4):30.

PMID: 23560230 PMC: 3616305. DOI: 10.1177/2042533313475576.

References

Gum P, Kottke-Marchant K, Poggio E, Gurm H, Welsh P, Brooks L . Profile and prevalence of aspirin resistance in patients with cardiovascular disease. Am J Cardiol. 2001; 88(3):230-5. DOI: 10.1016/s0002-9149(01)01631-9. View

. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ. 2002; 324(7329):71-86. PMC: 64503. DOI: 10.1136/bmj.324.7329.71. View

Eikelboom J, Hirsh J, Weitz J, Johnston M, Yi Q, Yusuf S . Aspirin-resistant thromboxane biosynthesis and the risk of myocardial infarction, stroke, or cardiovascular death in patients at high risk for cardiovascular events. Circulation. 2002; 105(14):1650-5. DOI: 10.1161/01.cir.0000013777.21160.07. View

Mosca L . C-reactive protein--to screen or not to screen?. N Engl J Med. 2002; 347(20):1615-7. DOI: 10.1056/NEJMe020127. View

Bhatt D, Topol E . Scientific and therapeutic advances in antiplatelet therapy. Nat Rev Drug Discov. 2003; 2(1):15-28. DOI: 10.1038/nrd985. View

Helgason C, Bolin K, Hoff J, Winkler S, Mangat A, Tortorice K . Development of aspirin resistance in persons with previous ischemic stroke. Stroke. 1994; 25(12):2331-6. DOI: 10.1161/01.str.25.12.2331. View

Gum P, Kottke-Marchant K, Welsh P, White J, Topol E . A prospective, blinded determination of the natural history of aspirin resistance among stable patients with cardiovascular disease. J Am Coll Cardiol. 2003; 41(6):961-5. DOI: 10.1016/s0735-1097(02)03014-0. View

Patrono C . Aspirin resistance: definition, mechanisms and clinical read-outs. J Thromb Haemost. 2003; 1(8):1710-3. DOI: 10.1046/j.1538-7836.2003.00284.x. View

de Gaetano G, Cerletti C . Aspirin resistance: a revival of platelet aggregation tests?. J Thromb Haemost. 2003; 1(9):2048-50. DOI: 10.1046/j.1538-7836.2003.00354.x. View

10.

Kurth T, Glynn R, Walker A, Chan K, Buring J, Hennekens C . Inhibition of clinical benefits of aspirin on first myocardial infarction by nonsteroidal antiinflammatory drugs. Circulation. 2003; 108(10):1191-5. DOI: 10.1161/01.CIR.0000087593.07533.9B. View

11.

MacDonald T, Wei L . Effect of ibuprofen on cardioprotective effect of aspirin. Lancet. 2003; 361(9357):573-4. DOI: 10.1016/s0140-6736(03)12509-3. View